| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |